trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Patients with mechanical heart valves generally require lifelong blood thinner medication to prevent blood clots.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
5 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that patients with mechanical heart valves generally require lifelong blood thinner medication to prevent blood clots?

Yes. Patients who receive mechanical heart valves require lifelong anticoagulant therapy to reduce the risk of potentially fatal blood clots forming on the artificial valve components.

Verdict: SUPPORTED · 5 sources for, 0 against · Last checked

The analysis

The claim is a well-established clinical consensus supported consistently across the provided literature, which highlights that mechanical heart valves require permanent anticoagulation to prevent thrombosis while managing bleeding risks.

Evidence for · 5
2003
This case report discusses a patient with a St. Jude mechanical heart valve receiving long-term anticoagulant therapy.
Get citation
Pegoraro, C., Biasiolo, A., Iliceto, S., & Pengo, V. (2003). Mechanical Prosthetic Heart Valve Thrombosis Despite Optimal Anticoagulation in a Patient with Congenital Thrombophilia (Factor V Leiden). doi.org. https://doi.org/10.1177/107602960300900112

See more details
More for · 4
2026
This study highlights that patients with mechanical heart valves require lifelong anticoagulation to prevent thromboembolic events, exposing them to bleeding risks.
Get citation
J, F., RE, B., C, K., Y, K., HC, P., T, G., M, M., I, T., P, R., O, D., & H, R. C. B. (2026). Traumatic brain injury in patients with mechanical heart valves on lifelong anticoagulation: incidence, management, and outcomes of intracranial hemorrhage.. doi.org. https://doi.org/10.3389/fcvm.2026.1874285

2026
This case study confirms that mechanical prostheses mandate lifelong anticoagulation in patients following valve replacement.
Get citation
X, L., X, Y., T, S., & X, Y. (2026). Perioperative management in a patient with congenital factor VII deficiency following mechanical valve replacement: a case report.. doi.org. https://doi.org/10.1186/s12959-026-00886-1

2026
This case report notes the management of anticoagulant therapy in a young patient with a mechanical aortic valve.
Get citation
MO, H., HO, H., NM, H., & AE, A. (2026). Life-Threatening Spontaneous Retroperitoneal Hemorrhage Associated with Acenocoumarol Anticoagulation in a Young Patient with a Mechanical Aortic Valve: A Case Report.. doi.org. https://doi.org/10.2147/imcrj.s623300

2026
This case study reiterates that warfarin remains the standard anticoagulant of choice for chronic use in patients with mechanical heart valves.
Get citation
KN, S., PL, T., & TE, H. (2026). Delayed Traumatic Subarachnoid Hemorrhage Following Initially Negative Computed Tomography (CT) Imaging in a Patient With a Mechanical Mitral Valve and Markedly Elevated International Normalized Ratio (INR).. doi.org. https://doi.org/10.7759/cureus.113580

What does the evidence say?

The claim is a well-established clinical consensus supported consistently across the provided literature, which highlights that mechanical heart valves require permanent anticoagulation to prevent thrombosis while managing bleeding risks.

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work